Cargando…

Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis

Vascular endothelial dysfunction (VED) is an important factor in the initiation and development of atherosclerosis (AS). Previous studies have demonstrated that endothelial permeability is increased in diet-induced AS. However, the precise underlying mechanisms remain poorly understood. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: CHENG, XIAOWEN, WANG, XIAOBIAN, WAN, YUFENG, ZHOU, QING, ZHU, HUAQING, WANG, YUAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526030/
https://www.ncbi.nlm.nih.gov/pubmed/26096176
http://dx.doi.org/10.3892/mmr.2015.3973
_version_ 1782384368760651776
author CHENG, XIAOWEN
WANG, XIAOBIAN
WAN, YUFENG
ZHOU, QING
ZHU, HUAQING
WANG, YUAN
author_facet CHENG, XIAOWEN
WANG, XIAOBIAN
WAN, YUFENG
ZHOU, QING
ZHU, HUAQING
WANG, YUAN
author_sort CHENG, XIAOWEN
collection PubMed
description Vascular endothelial dysfunction (VED) is an important factor in the initiation and development of atherosclerosis (AS). Previous studies have demonstrated that endothelial permeability is increased in diet-induced AS. However, the precise underlying mechanisms remain poorly understood. The present study aimed to analyze whether the myosin light chain kinase (MLCK) inhibitor ML7 is able to improve VED and AS by regulating the expression of the tight junction (TJ) proteins zona occludens (ZO)-1 and occludin via mechanisms involving MLCK and MLC phosphorylation in high-fat diet-fed rabbits. New Zealand white rabbits were randomly divided into three groups: Control group, AS group and ML7 group. The rabbits were fed a standard diet (control group), a high-fat diet (AS group) or a high-fat diet supplemented with 1 mg/kg/day ML7 (ML7 group). After 12 weeks, endothelium-dependent relaxation and endothelium-independent relaxation were measured using high-frequency ultrasound. Administration of a high-fat diet significantly increased the levels of serum lipids and inflammatory markers in the rabbits in the AS group, as compared with those in the rabbits in the control group. Furthermore, a high-fat diet contributed to the formation of a typical atherosclerotic plaque, as well as an increase in endothelial permeability and VED. These symptoms of AS were significantly improved following treatment with ML7, as demonstrated in the ML7 group. Hematoxylin & eosin and immunohistochemical staining indicated that ML7 was able to decrease the expression of MLCK and MLC phosphorylation in the arterial wall of rabbits fed a high-fat diet. A similar change was observed for the TJ proteins ZO-1 and occludin. In addition, western blot analysis demonstrated that ML7 increased the expression levels of occludin in the precipitate, but reduced its expression in the supernatant of lysed aortas. These results indicated that occludin, which is a dynamic protein at the TJ, is associated with remodeling from cell membrane to cytoplasm. The present study was the first, to the best of our knowledge, to indicate that ML7 may ameliorate VED and AS by regulating the TJ proteins ZO-1 and occludin via mechanisms involving MLCK and MLC phosphorylation.
format Online
Article
Text
id pubmed-4526030
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-45260302015-11-30 Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis CHENG, XIAOWEN WANG, XIAOBIAN WAN, YUFENG ZHOU, QING ZHU, HUAQING WANG, YUAN Mol Med Rep Articles Vascular endothelial dysfunction (VED) is an important factor in the initiation and development of atherosclerosis (AS). Previous studies have demonstrated that endothelial permeability is increased in diet-induced AS. However, the precise underlying mechanisms remain poorly understood. The present study aimed to analyze whether the myosin light chain kinase (MLCK) inhibitor ML7 is able to improve VED and AS by regulating the expression of the tight junction (TJ) proteins zona occludens (ZO)-1 and occludin via mechanisms involving MLCK and MLC phosphorylation in high-fat diet-fed rabbits. New Zealand white rabbits were randomly divided into three groups: Control group, AS group and ML7 group. The rabbits were fed a standard diet (control group), a high-fat diet (AS group) or a high-fat diet supplemented with 1 mg/kg/day ML7 (ML7 group). After 12 weeks, endothelium-dependent relaxation and endothelium-independent relaxation were measured using high-frequency ultrasound. Administration of a high-fat diet significantly increased the levels of serum lipids and inflammatory markers in the rabbits in the AS group, as compared with those in the rabbits in the control group. Furthermore, a high-fat diet contributed to the formation of a typical atherosclerotic plaque, as well as an increase in endothelial permeability and VED. These symptoms of AS were significantly improved following treatment with ML7, as demonstrated in the ML7 group. Hematoxylin & eosin and immunohistochemical staining indicated that ML7 was able to decrease the expression of MLCK and MLC phosphorylation in the arterial wall of rabbits fed a high-fat diet. A similar change was observed for the TJ proteins ZO-1 and occludin. In addition, western blot analysis demonstrated that ML7 increased the expression levels of occludin in the precipitate, but reduced its expression in the supernatant of lysed aortas. These results indicated that occludin, which is a dynamic protein at the TJ, is associated with remodeling from cell membrane to cytoplasm. The present study was the first, to the best of our knowledge, to indicate that ML7 may ameliorate VED and AS by regulating the TJ proteins ZO-1 and occludin via mechanisms involving MLCK and MLC phosphorylation. D.A. Spandidos 2015-09 2015-06-22 /pmc/articles/PMC4526030/ /pubmed/26096176 http://dx.doi.org/10.3892/mmr.2015.3973 Text en Copyright © 2015, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
CHENG, XIAOWEN
WANG, XIAOBIAN
WAN, YUFENG
ZHOU, QING
ZHU, HUAQING
WANG, YUAN
Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
title Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
title_full Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
title_fullStr Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
title_full_unstemmed Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
title_short Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
title_sort myosin light chain kinase inhibitor ml7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526030/
https://www.ncbi.nlm.nih.gov/pubmed/26096176
http://dx.doi.org/10.3892/mmr.2015.3973
work_keys_str_mv AT chengxiaowen myosinlightchainkinaseinhibitorml7improvesvascularendothelialdysfunctionviatightjunctionregulationinarabbitmodelofatherosclerosis
AT wangxiaobian myosinlightchainkinaseinhibitorml7improvesvascularendothelialdysfunctionviatightjunctionregulationinarabbitmodelofatherosclerosis
AT wanyufeng myosinlightchainkinaseinhibitorml7improvesvascularendothelialdysfunctionviatightjunctionregulationinarabbitmodelofatherosclerosis
AT zhouqing myosinlightchainkinaseinhibitorml7improvesvascularendothelialdysfunctionviatightjunctionregulationinarabbitmodelofatherosclerosis
AT zhuhuaqing myosinlightchainkinaseinhibitorml7improvesvascularendothelialdysfunctionviatightjunctionregulationinarabbitmodelofatherosclerosis
AT wangyuan myosinlightchainkinaseinhibitorml7improvesvascularendothelialdysfunctionviatightjunctionregulationinarabbitmodelofatherosclerosis